Actively Recruiting
Tamoxifen for Advanced Solid Pseudopapillary Tumor of the Pancreas
Led by Fudan University · Updated on 2025-04-06
30
Participants Needed
1
Research Sites
153 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Tamoxifen for Solid Pseudopapillary Tumor of the Pancreas
CONDITIONS
Official Title
Tamoxifen for Advanced Solid Pseudopapillary Tumor of the Pancreas
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age between 14 and 80 years
- Histologically confirmed advanced solid pseudopapillary tumor of the pancreas with estrogen/progesterone receptor positivity
- Advanced disease defined by unresectable primary tumor or distant metastases (liver, lung, peritoneum, etc.) or recurrent/refractory status after prior surgery or systemic therapy
- At least one measurable tumor lesion
- Eastern Cooperative Oncology Group (ECOG) performance status of 0 to 2
- Life expectancy of at least 1 month
- Ability to comply with study visits and take oral medication as required
You will not qualify if you...
- Pathology other than solid pseudopapillary tumor of the pancreas
- Active gastrointestinal inflammation or infection, such as pancreatitis
- Pregnancy or breastfeeding
- Severe organ dysfunction affecting kidneys, heart, liver, or lungs
- Uncontrolled medical conditions including central nervous system disorders or unstable angina
- Any condition that could compromise patient safety or the integrity of study data
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Shanghai Cancer Center
Shanghai, China, 200032
Actively Recruiting
Research Team
H
Huanyu Xia MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here